Can a Parkinson's drug clear long COVID brain fog?
NCT ID NCT06055244
First seen Jan 29, 2026 · Last updated May 04, 2026 · Updated 15 times
Summary
This study tested whether amantadine, a drug used for Parkinson's, can improve thinking and memory problems in people with Long COVID. 64 adults with brain fog after a COVID infection took part. Researchers also looked for clues in blood samples to see who might benefit most.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Ohio State University Medical Center
Columbus, Ohio, 43221, United States
Conditions
Explore the condition pages connected to this study.